Pathophysiology of Sickle Cell Anemia in India for Kenyan Patients

GetWellGo explains sickle cell anemia pathophysiology in India, helping Kenyan patients learn about genetic factors, disease progression, and new care options.

Pathophysiology of Sickle Cell Anemia in India for Kenyan Patients

  • Category

    General

  • Published By

    GetWellGo Team

  • Updated on

    10-Feb-2026

Pathophysiology of sickle cell anemia

The pathophysiology of this disease is a cascade of related events:   

Genetic Mutation and the Structure of Hemoglobin

  • Origin: Single base pair mutation in the β-globin gene on chromosome 11.
  • Result: A glutamic acid was replaced with a valine at the 6th amino acid position in the β-globin chain.
  • Effect: They produce sickle hemoglobin and not the regular adult haemoglobin.

Polymerization of Hemoglobin S 

  • At low oxygen (hypoxic) tension HbS polymerizes (gels) and forms long, rigid rods.
  • This causes red blood cells (RBCs) to take on a sickled or crescent shape. 

Red Blood Cell Sickling

Sickled RBCs are:

  • Hard and less flexible
  • Susceptible to hemolysis (breaking up prematurely)
  • Have a shorter life span (~10–20 days compared to 120 days for healthy RBCs)

Vaso-occlusion

Sickled cells:

  • Become trapped in small capillaries
  • Induce obstructions (vaso-occlusion) in blood vessels
  • Lead to tissue ischemia, pain (sickle cell crises), and organ injury

Hemolysis and Anaemia

Progressive destruction of sickle cells results in:

  • Hemolytic anemia levels
  • Hyperbilirubinemia 
  • Gallstones 

Inflammation and Endothelial Dysfunction

Vaso-occlusion and ischemia lead to:

  • Inflammatory cytokines
  • Endothelial activation and damage
  • More adhesion of leukocytes and sickled cells to blood vessel walls

Pathophysiology of sickle cell anemia India Kenyans

Sickle Cell Anemia is a genetic blood condition that causes red blood cells to become abnormally shaped, leading to the formation of chronic anemia, pain crises, infections, and organ damage. It holds in parts of Kenya and sub-Saharan Africa and that many patients travel to India for high quality hematology and transplant care at a fraction of the cost. 

Why India have so many Kenyan patients?

The hospitals in India have the following to offer:

  • Advanced blood tests and genetic analysis.
  • Regular transfusion procedures.
  • Hydroxyurea treatments
  • Bone marrow/stem cell transplants. 
  • Specialized international patient care.

Genetic Cause

  • The cause of sickle cell anemia is a gene mutation that each parent must pass on for their child to develop the disease.
  • The mutant gene produces a defective form of hemoglobin called Hemoglobin S (HbS) compared to the normal Hemoglobin A (HbA).
  • Normal hemoglobin - makes it easy for the body to transport oxygen.
  • O2 levels drop, HbS polymerizes – becomes sticky and rigid. 

Red Blood Cell Shape Change

Under low oxygen conditions (such as in infection, dehydration, or stress) HbS causes red blood cells to: 

  • Transformation of a round and flexible form.
  • And into a crescent or a sickle shape.

These sickled cells:

  • Which should not flow through blood vessels easily
  • Lyses up excessively rapidly RBCs.

Chronic Anemia Development

  • Normal RBCs live for about 120 days, and sick cells live for about 10-20 days. 

This leads to:

  • Recurrent deficiency of red blood cells.
  • Limited supply of oxygen to the body organs.
  • Like fatigue, shortness of breath, and slowed growth in children.

Blockage of the blood vessels (vaso-occlusion)

  • It is also possible for the sickled cells to stick to the blood vessel walls and cause blockages. 

This results in:

  • Extreme episodes of pain (referred to as pain crisis)
  • Organ damage over time
  • Risk of stroke, chest infections, renal failure and bone disease.

Enhanced infection risk 

  • The sickle cell disease destroys the spleen which is used to combat infections.

Therefore, patients are at greater risk of:

  • Bacterial infections
  • Malaria 
  • Pneumonia and sepsis - the usual suspects

Organ damage and hypoxia 

The organization of blood supply results in inadequate oxygen supply (ischemia) of the essential organs like:

  • Brain → stroke risk
  • Lungs → Acute Chest Syndrome
  • Kidneys → Chronic Kidney Disease.
  • Bone avascular necrosis and joint destruction → Osteonecrosis of bones and joint damage. 

The reason behind Indian Hospitals on Advanced Monitoring

In the case of Kenyan patients who get treatment in India, physicians closely observe:

  • Hemoglobin levels
  • Blood oxygen levels
  • Organs of the system (heart, kidneys, brain) 
  • Infection markers

This will assist in avoiding complication and leading to treatments such as:

  • Hydroxyurea treatment
  • Blood transfusion
  • Stem cell or marrow transplant (potential cure for some patients)

Pathophysiology of sickle cell anemia complications

Sickle Cell Anemia is an incurable hereditary condition of the blood that is likely to cause severe complications otherwise. Kenyan patients also go to India in large numbers to receive improved and affordable care that includes long-term medical care and curative transplant procedures.

Common Complications of Sickle Cell Anemia:

  • Pain Crises
  • Severe Infections
  • Stroke
  • Acute Chest Syndrome
  • Chronic Anemia & Fatigue
  • Kidney Damage
  • Bone & Joint Problems
  • Vision Problems
  • Growth and puberty that proceed at a slower rate than usual.

Conclusion

Sickle cell anemia (SCA) is a multifactorial genetic blood disorder with a single mutational origin of abnormal hemoglobin production, red blood cell sickling, chronic hemolysis, vaso-occlusion, inflammation, and end-organ injury. These pathophysiologic events collectively lead to the key clinical manifestations of the disease-episodic pain attacks, susceptibility to infection, risk of stroke, acute pulmonary disease, renal and bony injury, and shortened lifespan in the absence of adequate medical care. Comprehensive, accessible and affordable care over a long period is essential for patients with sickle cell disease, such as those in Kenya, where the disease is quite common. It has been recognized as a favoured destination owing to sophisticated diagnostic facilities, expert haematologists with a well organization monitoring framework and the presence of supportive care (hydroxyurea, blood transfusions, infection prevention) along with curative modalities in the form of bone marrow or stem cell transplant. By intervening in the affected pathophysiology at multiple points including genetic, cellular, vascular, and organ-specific levels, Indian hospitals can minimize complications, enhance quality of life, and, in limited cases, provide the possibility of a cure. This comprehensive package positions India as a leading treatment center for Kenyan individuals looking for the best, most affordable treatment for sickle cell anemia.

Pathophysiology of sickle cell anemia India GetWellGo Kenyans

GetWellGo is regarded as a leading supplier of healthcare services. We help Kenyan patients choose the best treatment locations that suit their needs both financially and medically.

We offer:

  • Complete transparency
  • Fair costs.
  • 24 hour availability.
  • Medical E-visas
  • Online consultation from recognized Indian experts.
  • Assistance in selecting India's top hospitals for sickle cell anemia treatment.
  • Expert haematologists with a strong track record of success
  • Assistance during and after the course of treatment.
  • Language Support
  • Travel and Accommodation Services
  • Case manager assigned to every patient to provide seamless support in and out of the hospital like appointment booking
  • Local SIM Cards
  • Currency Exchange
  • Arranging Patient’s local food

 

Recent Blogs